[When is aftercare useful in renal cell cancer?].
Diagnosis of tumor recurrence and of therapy-related side effects as well as psychological support are the main goals of a surveillance program of cancer patients. While the latter may represent a time-consuming effort, most diagnostic procedures are expensive. Whether we can efficiently detect tumor recurrence in renal cell carcinoma depends on various parameters of the recurrent disease (e.g., frequency, localization, or therapeutic options). Available data lend support to "lean" follow-up strategies in patients with renal cell carcinoma.
Ebert
T
T
Urologische Belegabteilung, EuromedClinic, Fürth. ebert@euromed.de
Fischer
C
C
D000359:Aftercare / Q000379:methods*; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000628:therapy*; D010166:Palliative Care / Q000379:methods; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D013727:Terminal Care / Q000379:methods; D016896:Treatment Outcome